Evommune, Inc. (NYSE:EVMN) Financings
Financings
| Raise | Date |
|---|---|
| Private placement of common stock Announced: about US$125M · US$27.88 a share · Morgan Stanley & Co. LLC +5 Dealers: Morgan Stanley & Co. LLC, Leerink Partners LLC, Evercore ISI, Cantor Fitzgerald & Co., William Blair & Company, L.L.C., Oppenheimer & Co. Inc. Use of proceeds: To advance its clinical development programs and for general corporate purposes | Feb 13, 2026 |
| Public offering of common stock Update: US$150M · US$16 a share · Morgan Stanley +3 Dealers: Morgan Stanley (co-lead), Leerink Partners (co-lead), Evercore ISI (co-lead), Cantor (co-lead) | Nov 6, 2025 |